|
1
|
Jonasson F, Fisher DE, Eiriksdottir G,
Sigurdsson S, Klein R, Launer LJ, Harris T, Gudnason V and Cotch
MF: Five-year incidence, progression, and risk factors for
age-related macular degeneration: The age, gene/environment
susceptibility study. Ophthalmology. 121:1766–1772. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Afarid M, Azimi A and Malekzadeh M:
Evaluation of serum interferons in patients with age-related
macular degeneration. J Res Med Sci. 24(24)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Apte RS, Chen DS and Ferrara N: VEGF in
signaling and disease: Beyond discovery and development. Cell.
176:1248–1264. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kim KJ, Li B, Winer J, Armanini M, Gillett
N, Phillips HS and Ferrara N: Inhibition of vascular endothelial
growth factor-induced angiogenesis suppresses tumour growth in
vivo. Nature. 362:841–844. 1993.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Schlottmann PG, Alezzandrini AA, Zas M,
Rodriguez FJ, Luna JD and Wu L: New treatment modalities for
neovascular age-related macular degeneration. Asia Pac J Ophthalmol
(Phila). 6:514–519. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nguyen QD, Das A, Do DV, Dugel PU, Gomes
A, Holz FG, Koh A, Pan CK, Sepah YJ, Patel N, et al: Brolucizumab:
Evolution through preclinical and clinical studies and the
implications for the management of neovascular age-related macular
degeneration. Ophthalmology. 127:963–976. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Borrelli E, Parravano M, Sacconi R,
Costanzo E, Querques L, Vella G, Bandello F and Querques G:
Guidelines on optical coherence tomography angiography imaging:
2020 Focused update. Ophthalmol Ther. 9:697–707. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Borrelli E, Sarraf D, Freund KB and Sadda
SR: OCT angiography and evaluation of the choroid and choroidal
vascular disorders. Prog Retin Eye Res. 67:30–55. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jia Y, Bailey ST, Wilson DJ, Tan O, Klein
ML, Flaxel CJ, Potsaid B, Liu JJ, Lu CD, Kraus MF, et al:
Quantitative optical coherence tomography angiography of choroidal
neovascularization in age-related macular degeneration.
Ophthalmology. 121:1435–1444. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ashraf M, Souka A and Adelman RA:
Age-related macular degeneration: Using morphological predictors to
modify current treatment protocols. Acta Ophthalmol. 96:120–133.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Inoue M, Jung JJ, Balaratnasingam C,
Dansingani KK, Dhrami-Gavazi E, Suzuki M, de Carlo TE, Shahlaee A,
Klufas MA, El Maftouhi A, et al: A comparison between optical
coherence tomography angiography and fluorescein angiography for
the imaging of type 1 neovascularization. Invest Ophthalmol Vis
Sci. 57:OCT314–OCT323. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hsu CR, Lai TT, Hsieh YT, Ho TC, Yang CM
and Yang CH: Combined quantitative and qualitative optical
coherence tomography angiography biomarkers for predicting active
neovascular age-related macular degeneration. Sci Rep.
11(18068)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Arrigo A, Aragona E, Bordato A, Amato A,
Borghesan F, Bandello F and Parodi MB: Quantitative optical
coherence tomography angiography parameter variations after
treatment of macular neovascularization secondary to age-related
macular degeneration. Retina. 41:1463–1469. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shin YI, Kim JM, Lee MW, Jo YJ and Kim JY:
Characteristics of the foveal microvasculature in asian patients
with dry age-related macular degeneration: An optical coherence
tomography angiography study. Ophthalmologica. 243:145–153.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Su L, Ji YS, Tong N, Sarraf D, He X, Sun
X, Xu X and Sadda SR: Quantitative assessment of the retinal
microvasculature and choriocapillaris in myopic patients using
swept-source optical coherence tomography angiography. Graefes Arch
Clin Exp Ophthalmol. 258:1173–1180. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tew TB, Lai TT, Hsieh YT, Ho TC, Yang CM
and Yang CH: Comparison of different morphologies of choroidal
neovascularization evaluated by ocular coherence tomography
angiography in age-related macular degeneration. Clin Exp
Ophthalmol. 48:927–937. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Spaide RF, Jaffe GJ, Sarraf D, Freund KB,
Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ,
Holz FG, et al: Consensus nomenclature for reporting neovascular
age-related macular degeneration data: Consensus on neovascular
age-related macular degeneration nomenclature study group.
Ophthalmology. 127:616–636. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Takeuchi J, Kataoka K, Ito Y, Takayama K,
Yasuma T, Kaneko H and Terasaki H: Optical coherence tomography
angiography to quantify choroidal neovascularization in response to
aflibercept. Ophthalmologica. 240:90–98. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liang MC, de Carlo TE, Baumal CR, Reichel
E, Waheed NK, Duker JS and Witkin AJ: Correlation of spectral
domain optical coherence tomography angiography and clinical
activity in neovascular age-related macular degeneration. Retina.
36:2265–2273. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Eandi CM, Ciardella A, Parravano M,
Missiroli F, Alovisi C, Veronese C, Morara MC, Grossi M, Virgili G
and Ricci F: Indocyanine green angiography and optical coherence
tomography angiography of choroidal neovascularization in
age-related macular degeneration. Invest Ophthalmol Vis Sci.
58:3690–3696. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Coscas GJ, Lupidi M, Coscas F, Cagini C
and Souied EH: Optical coherence tomography angiography versus
traditional multimodal imaging in assessing the activity of
exudative age-related macular degeneration: A new diagnostic
challenge. Retina. 35:2219–2228. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Roberts PK, Nesper PL, Gill MK and Fawzi
AA: Semiautomated quantitative approach to characterize treatment
response in neovascular age-related macular degeneration: A
real-world study. Retina. 37:1492–1498. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
El Ameen A, Cohen SY, Semoun O, Miere A,
Srour M, Quaranta-El Maftouhi M, Oubraham H, Blanco-Garavito R,
Querques G and Souied EH: Type 2 neovascularization secondary to
age-related macular degeneration imaged by optical coherence
tomography angiography. Retina. 35:2212–2218. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Carlo TE, Bonini Filho MA, Chin AT,
Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS and
Waheed NK: Spectral-domain optical coherence tomography angiography
of choroidal neovascularization. Ophthalmology. 122:1228–1238.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kuehlewein L, Bansal M, Lenis TL, Iafe NA,
Sadda SR, Bonini Filho MA, De Carlo TE, Waheed NK, Duker JS and
Sarraf D: Optical coherence tomography angiography of type 1
neovascularization in age-related macular degeneration. Am J
Ophthalmol. 160:739–748.e2. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Karacorlu M, Sayman Muslubas I, Arf S,
Hocaoglu M and Ersoz MG: Membrane patterns in eyes with choroidal
neovascularization on optical coherence tomography angiography. Eye
(Lond). 33:1280–1289. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Comparison of Age-related Macular
Degeneration Treatments Trials (CATT) Research Group. Martin DF,
Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C,
Redford M and Ferris FL III: Ranibizumab and bevacizumab for
treatment of neovascular age-related macular degeneration: Two-year
results. Ophthalmology. 119:1388–1398. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Told R, Reumueller A, Schranz M, Brugger
J, Weigert G, Reiter GS, Sacu S and Schmidt-Erfurth U: OCTA
biomarker search in patients with nAMD: Influence of retinal fluid
on time-dependent biomarker response. Curr Eye Res. 48:600–604.
2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Faatz H, Rothaus K, Ziegler M, Book M,
Spital G, Lange C and Lommatzsch A: The architecture of macular
neovascularizations predicts treatment responses to anti-VEGF
therapy in neovascular AMD. Diagnostics (Basel).
12(2807)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Arya M, Rashad R, Sorour O, Moult EM,
Fujimoto JG and Waheed NK: Optical coherence tomography angiography
(OCTA) flow speed mapping technology for retinal diseases. Expert
Rev Med Devices. 15:875–882. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kanadani TCM, Veloso CE and Nehemy MB:
Subfoveal choroidal thickness in eyes with neovascular age-related
macular degeneration treated with anti-vascular endothelial growth
factor agents. Ophthalmologica. 240:200–207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Miere A, Butori P, Cohen SY, Semoun O,
Capuano V, Jung C and Souied EH: Vascular remodeling of choroidal
neovascularization after anti-vascular endothelial growth factor
therapy visualized on optical coherence tomography angiography.
Retina. 39:548–557. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Miere A, Semoun O, Cohen SY, El Ameen A,
Srour M, Jung C, Oubraham H, Querques G and Souied EH: Optical
coherence tomography angiography features of subretinal fibrosis in
age-related macular degeneration. Retina. 35:2275–2284.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Al-Sheikh M, Iafe NA, Phasukkijwatana N,
Sadda SR and Sarraf D: Biomarkers of neovascular activity in
age-related macular degeneration using optical coherence tomography
angiography. Retina. 38:220–230. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Levine ES, Custo Greig E, Mendonça LSM,
Gulati S, Despotovic IN, Alibhai AY, Moult E, Muakkassa N,
Quaranta-El Maftouhi M, El Maftouhi A, et al: The long-term effects
of anti-vascular endothelial growth factor therapy on the optical
coherence tomography angiographic appearance of neovascularization
in age-related macular degeneration. Int J Retina Vitreous.
6(39)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lumbroso B, Rispoli M and Savastano MC:
Longitudinal optical coherence tomography-angiography study of type
2 naive choroidal neovascularization early response after
treatment. Retina. 35:2242–2251. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Told R, Reiter GS, Schranz M, Reumueller
A, Hacker V, Mittermueller TJ, Roberts PK, Sacu S and
Schmidt-Erfurth U: Correlation of retinal thickness and
swept-source optical coherence tomography angiography derived
vascular changes in patients with neovascular age-related macular
degeneration. Curr Eye Res. 46:1002–1009. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Arrigo A, Aragona E, Bordato A, Amato A,
Borghesan F, Bandello F and Battaglia Parodi M: Morphological and
functional relationship between OCTA and FA/ICGA quantitative
features in AMD-related macular neovascularization. Front Med
(Lausanne). 8(758668)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ahmed M, Syrine BM, Nadia BA, Anis M,
Karim Z, Mohamed G, Hachemi M, Fethi K and Leila K: Optical
coherence tomography angiography features of macular
neovascularization in wet age-related macular degeneration: A
cross-sectional study. Ann Med Surg (Lond).
70(102826)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Carnevali A, Cicinelli MV, Capuano V,
Corvi F, Mazzaferro A, Querques L, Scorcia V, Souied EH, Bandello F
and Querques G: Optical coherence tomography angiography: A useful
tool for diagnosis of treatment-Naïve quiescent choroidal
neovascularization. Am J Ophthalmol. 169:189–198. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rush RB, Rush SW, Aragon AV II and Ysasaga
JE: Evaluation of choroidal neovascularization with indocyanine
green angiography in neovascular age-related macular degeneration
subjects undergoing intravitreal bevacizumab therapy. Am J
Ophthalmol. 158:337–344. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Horner F, Lip PL, Clark H, Chavan R,
Sarmad A and Mushtaq B: Real-world visual and clinical outcomes for
patients with neovascular age-related macular degeneration treated
with intravitreal ranibizumab: An 8-year observational cohort
(AMD8). Clin Ophthalmol. 13:2461–2467. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jacob J, Brié H, Leys A, Levecq L,
Mergaerts F, Denhaerynck K, Vancayzeele S, Van Craeyveld E, Abraham
I and MacDonald K: Six-year outcomes in neovascular age-related
macular degeneration with ranibizumab. Int J Ophthalmol. 10:81–90.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gillies MC, Campain A, Barthelmes D,
Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Essex RW, Morlet N
and Hunyor AP: Fight Retinal Blindness Study Group. Long-term
outcomes of treatment of neovascular age-related macular
degeneration: Data from an observational study. Ophthalmology.
122:1837–1845. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Rofagha S, Bhisitkul RB, Boyer DS, Sadda
SR and Zhang K: SEVEN-UP Study Group. Seven-year outcomes in
ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: A
multicenter cohort study (SEVEN-UP). Ophthalmology. 120:2292–2299.
2013.PubMed/NCBI View Article : Google Scholar
|
